Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-07
1997-07-01
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514565, 514742, 514843, A61K 3134, A61K 31195, A61K 31045
Patent
active
056439440
ABSTRACT:
The stimulation of ovulation in a female may be achieved by administering a nitric oxide source, optionally in further combination with one or more of clomiphene, a gonadotropin, and an LH-RH agonist.
REFERENCES:
patent: 4339434 (1982-07-01), Ericsson
patent: 4851385 (1989-07-01), Rueske
patent: 5068221 (1991-11-01), Mathias
patent: 5130137 (1992-07-01), Crowley, Jr.
Bonello et al., "Inhibition of Nitric Oxide: Effects on Interleukin-1.beta.-Enhanced Ovulation Rate, Steriod Hormones, and Ovarian Leukocyte Distribution at Ovulation in the Rat, " Biology of Reproduction, 54:436-445, 1996.
Mani et al., "Nitric Oxide Mediates Sexual Behavior in Female Rats," Proc. Natl. Acad. Sci., 91:6468-6472, Jul. 1994.
Shukovski and Tsafriri, "The Involvement of Nitric Oxide in the Ovulatory Process in the Rat," Endocrinology, 135(5):2287-2290, 1994.
Van Voorhis et al., "Nitric Oxide: An Autocrine Regulator of Human Granulosa-Luteal Cell Steroidogenesis," 135(5):1799-1806, 1994.
Garfield Robert E.
Yallampalli Chandrasekhar
Board of Regents , The University of Texas System
Criares Theodore J.
LandOfFree
Ovulation control by regulating nitric oxide levels does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ovulation control by regulating nitric oxide levels, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ovulation control by regulating nitric oxide levels will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-597638